Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Hypertension. 2000;35:19-24

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horio, T.
Right arrow Articles by Kangawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horio, T.
Right arrow Articles by Kangawa, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENYLEPHRINE
Related Collections
Right arrow Other myocardial biology

(Hypertension. 2000;35:19.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Inhibitory Regulation of Hypertrophy by Endogenous Atrial Natriuretic Peptide in Cultured Cardiac Myocytes

Takeshi Horio; Toshio Nishikimi; Fumiki Yoshihara; Hisayuki Matsuo; Shuichi Takishita; Kenji Kangawa

From the Division of Hypertension, Department of Medicine (T.H., S.T.), and Research Institute (T.N., F.Y., H.M., K.K.), National Cardiovascular Center, Suita, Osaka, Japan.

Correspondence to Takeshi Horio, MD, Division of Hypertension, Department of Medicine, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita, Osaka 565-8565, Japan. E-mail thorio{at}jsc.ri.ncvc.go.jp

Abstract—Atrial natriuretic peptide (ANP) may function as an endogenous regulator of cardiac hypertrophy, because the natriuretic peptide receptor has been found in the heart and because mice lacking its receptor have been shown to have a markedly elevated ventricular mass. We examined the role of endogenous ANP in cardiac hypertrophy in vitro. The effects of the blockade of endogenous ANP by its receptor antagonist, HS-142–1, on cell hypertrophy were investigated with the use of cultured neonatal rat ventricular myocytes. HS-142–1 increased the basal and phenylephrine (PE, 10-5 mol/L)–stimulated protein syntheses in a concentration-dependent manner (1 to 300 µg/mL). A significant increase in the cell size of myocytes was also induced by this antagonist. In addition, the expression levels of skeletal {alpha}-actin, ß-myosin heavy chain, and ANP genes, markers of hypertrophy, were partially elevated by treatment with HS-142–1 (100 µg/mL) under nonstimulated or PE-stimulated conditions. A cGMP-specific phosphodiesterase inhibitor, zaprinast (5x10-4 mol/L), and a cGMP analogue (10-4 mol/L) suppressed the basal and PE-stimulated protein syntheses. Our observations suggest that endogenous ANP inhibits cardiac myocyte hypertrophy under basal and PE-stimulated conditions, probably through a cGMP-dependent process. ANP may play a role as an autocrine factor in the regulation of cardiac myocyte growth.


Key Words: hypertrophy • atrial natriuretic peptide • autocrine-paracrine • myocytes




This article has been cited by other articles:


Home page
 EndocrinologyHome page
Y. Li, Y. Saito, K. Kuwahara, X. Rong, I. Kishimoto, M. Harada, Y. Adachi, M. Nakanishi, H. Kinoshita, M. Horiuchi, et al.
Guanylyl Cyclase-A Inhibits Angiotensin II Type 2 Receptor-Mediated Pro-Hypertrophic Signaling in the Heart
Endocrinology, August 1, 2009; 150(8): 3759 - 3765.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
Eur. Heart J., June 2, 2008; 29(12): 1485 - 1494.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. O. Schwenke, T. Tokudome, M. Shirai, H. Hosoda, T. Horio, I. Kishimoto, and K. Kangawa
Exogenous Ghrelin Attenuates the Progression of Chronic Hypoxia-Induced Pulmonary Hypertension in Conscious Rats
Endocrinology, January 1, 2008; 149(1): 237 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. B. Murray, J. D. Gardner, S. P. Levick, G. L. Brower, L. G. Morgan, and J. S. Janicki
Response of cardiac mast cells to atrial natriuretic peptide
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1216 - H1222.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S J. Sangaralingham, M Y. Tse, and S. C Pang
Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice
J. Endocrinol., July 1, 2007; 194(1): 143 - 152.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. E. Rame, M. H. Drazner, W. Post, R. Peshock, J. Lima, R. S. Cooper, and D. L. Dries
Corin I555(P568) Allele Is Associated With Enhanced Cardiac Hypertrophic Response to Increased Systemic Afterload
Hypertension, April 1, 2007; 49(4): 857 - 864.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
L. J Ellmers, N. J A Scott, J. Piuhola, N. Maeda, O. Smithies, C. M Frampton, A M. Richards, and V. A Cameron
Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis
J. Mol. Endocrinol., February 1, 2007; 38(2): 245 - 257.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
E. Takimoto and D. A. Kass
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Hypertension, February 1, 2007; 49(2): 241 - 248.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Li, S. Hashim, and M. B. Anand-Srivastava
Intracellular peptides of natriuretic peptide receptor-C inhibit vascular hypertrophy via Gq{alpha}/MAP kinase signaling pathways
Cardiovasc Res, December 1, 2006; 72(3): 464 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. D. Jarvis, M. T. Rademaker, L. J. Ellmers, M. J. Currie, J. L. McKenzie, B. R. Palmer, C. M. Frampton, A. M. Richards, and V. A. Cameron
Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles.
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1952 - H1958.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Laskowski, O. L. Woodman, A. H. Cao, G. R. Drummond, T. Marshall, D. M. Kaye, and R. H. Ritchie
Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes
Cardiovasc Res, October 1, 2006; 72(1): 112 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Tsujita, J. Muraski, I. Shiraishi, T. Kato, J. Kajstura, P. Anversa, and M. A. Sussman
Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy
PNAS, August 8, 2006; 103(32): 11946 - 11951.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
B. London
Natriuretic Peptides and Cardiac Hypertrophy
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 506 - 507.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Rubattu, G. Bigatti, A. Evangelista, C. Lanzani, R. Stanzione, L. Zagato, P. Manunta, S. Marchitti, V. Venturelli, G. Bianchi, et al.
Association of Atrial Natriuretic Peptide and Type A Natriuretic Peptide Receptor Gene Polymorphisms With Left Ventricular Mass in Human Essential Hypertension
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 499 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. B. Margulies and J. C. Burnett Jr
Visualizing the Basis for Paracrine Natriuretic Peptide Signaling in Human Heart
Circ. Res., July 21, 2006; 99(2): 113 - 115.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
G. Singh, R. E. Kuc, J. J. Maguire, M. Fidock, and A. P. Davenport
Novel Snake Venom Ligand Dendroaspis Natriuretic Peptide Is Selective for Natriuretic Peptide Receptor-A in Human Heart: Downregulation of Natriuretic Peptide Receptor-A in Heart Failure
Circ. Res., July 21, 2006; 99(2): 183 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. A. Babiker, D. Lips, R. Meyer, E. Delvaux, P. Zandberg, B. Janssen, G. van Eys, C. Grohe, and P. A. Doevendans
Estrogen Receptor {beta} Protects the Murine Heart Against Left Ventricular Hypertrophy
Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1524 - 1530.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Nishikimi, N. Maeda, and H. Matsuoka
The role of natriuretic peptides in cardioprotection
Cardiovasc Res, February 1, 2006; 69(2): 318 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Murakami, N. Nagaya, T. Itoh, M. Kataoka, T. Iwase, T. Horio, Y. Miyahara, Y. Sakai, K. Kangawa, and H. Kimura
Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L59 - L65.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Luo, J. R. McMullen, C. L. Sobkiw, L. Zhang, A. L. Dorfman, M. C. Sherwood, M. N. Logsdon, J. W. Horner, R. A. DePinho, S. Izumo, et al.
Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy
Mol. Cell. Biol., November 1, 2005; 25(21): 9491 - 9502.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. B. Patel, M. L. Valencik, A. M. Pritchett, J. C. Burnett Jr., J. A. McDonald, and M. M. Redfield
Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H777 - H784.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Nakanishi, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, R. Kawakami, Y. Nakagawa, K. Tanimoto, S. Yasuno, et al.
Role of Natriuretic Peptide Receptor Guanylyl Cyclase-A in Myocardial Infarction Evaluated Using Genetically Engineered Mice
Hypertension, August 1, 2005; 46(2): 441 - 447.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Tokudome, T. Horio, I. Kishimoto, T. Soeki, K. Mori, Y. Kawano, M. Kohno, D. L. Garbers, K. Nakao, and K. Kangawa
Calcineurin-Nuclear Factor of Activated T Cells Pathway-Dependent Cardiac Remodeling in Mice Deficient in Guanylyl Cyclase A, a Receptor for Atrial and Brain Natriuretic Peptides
Circulation, June 14, 2005; 111(23): 3095 - 3104.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Nishikimi, J. R. Hagaman, N. Takahashi, H.-S. Kim, H. Matsuoka, O. Smithies, and N. Maeda
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene
Cardiovasc Res, April 1, 2005; 66(1): 94 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. C. Y. Chan, O. Knudson, F. Wu, J. Morser, W. P. Dole, and Q. Wu
Hypertension in mice lacking the proatrial natriuretic peptide convertase corin
PNAS, January 18, 2005; 102(3): 785 - 790.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M Jankowski, D Wang, S Mukaddam-Daher, and J Gutkowska
Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle
J. Endocrinol., January 1, 2005; 184(1): 209 - 217.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
V. Franco, Y.-F. Chen, S. Oparil, J. A. Feng, D. Wang, F. Hage, and G. Perry
Atrial Natriuretic Peptide Dose-Dependently Inhibits Pressure Overload-Induced Cardiac Remodeling
Hypertension, November 1, 2004; 44(5): 746 - 750.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A Luchner and H Schunkert
Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system
Cardiovasc Res, August 15, 2004; 63(3): 443 - 449.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Tokudome, T. Horio, M. Fukunaga, H. Okumura, J. Hino, K. Mori, F. Yoshihara, S.-I. Suga, Y. Kawano, M. Kohno, et al.
Ventricular Nonmyocytes Inhibit Doxorubicin-Induced Myocyte Apoptosis: Involvement of Endogenous Endothelin-1 as a Paracrine Factor
Endocrinology, May 1, 2004; 145(5): 2458 - 2466.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Tokudome, T. Horio, T. Soeki, K. Mori, I. Kishimoto, S.-i. Suga, F. Yoshihara, Y. Kawano, M. Kohno, and K. Kangawa
Inhibitory Effect of C-Type Natriuretic Peptide (CNP) on Cultured Cardiac Myocyte Hypertrophy: Interference between CNP and Endothelin-1 Signaling Pathways
Endocrinology, May 1, 2004; 145(5): 2131 - 2140.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. Magga, M. Puhakka, S. Hietakorpi, K. Punnonen, P. Uusimaa, J. Risteli, O. Vuolteenaho, H. Ruskoaho, and K. Peuhkurinen
Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction
J Appl Physiol, April 1, 2004; 96(4): 1306 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
I. E. Konstantinov, J. G. Coles, C. Boscarino, M. Takahashi, J. Goncalves, J. Ritter, and G. S. Van Arsdell
Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 746 - 754.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Mori, Y.-F. Chen, J. A. Feng, T. Hayashi, S. Oparil, and G. J Perry
Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse
Cardiovasc Res, March 1, 2004; 61(4): 771 - 779.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. B. Pilz and D. E. Casteel
Regulation of Gene Expression by Cyclic GMP
Circ. Res., November 28, 2003; 93(11): 1034 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. Wang, S. Oparil, J. A. Feng, P. Li, G. Perry, L. B. Chen, M. Dai, S. W.M. John, and Y.-F. Chen
Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide-Null Mouse
Hypertension, July 1, 2003; 42(1): 88 - 95.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. A. Cameron and L. J. Ellmers
Minireview: Natriuretic Peptides during Development of the Fetal Heart and Circulation
Endocrinology, June 1, 2003; 144(6): 2191 - 2194.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Horio, T. Tokudome, T. Maki, F. Yoshihara, S.-i. Suga, T. Nishikimi, M. Kojima, Y. Kawano, and K. Kangawa
Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts
Endocrinology, June 1, 2003; 144(6): 2279 - 2284.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Alexander, J. W. Knowles, T. Nishikimi, and N. Maeda
Increased Atherosclerosis and Smooth Muscle Cell Hypertrophy in Natriuretic Peptide Receptor A-/-Apolipoprotein E-/- Mice
Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1077 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. H. Kim, G. Y. Koh, K. W. Cho, W.-Y. Park, and J.-S. Seo
Stretch-Activated Atrial Natriuretic Peptide Secretion in Atria with Heat Shock Protein 70 Overexpression
Experimental Biology and Medicine, February 1, 2003; 228(2): 200 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. C Rosenkranz, R. L Woods, G. J Dusting, and R. H Ritchie
Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP
Cardiovasc Res, February 1, 2003; 57(2): 515 - 522.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
I. Boutin-Ganache, S. Picard, and C. F. Deschepper
Distinct gene-sex interactions regulate adult rat cardiomyocyte width and length independently
Physiol Genomics, December 26, 2002; 12(1): 61 - 67.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. C. Rosenkranz, S. G. Hood, R. L. Woods, G. J. Dusting, and R. H. Ritchie
Acute Antihypertrophic Actions of Bradykinin in the Rat Heart: Importance of Cyclic GMP
Hypertension, October 1, 2002; 40(4): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
Y. Li, I. Kishimoto, Y. Saito, M. Harada, K. Kuwahara, T. Izumi, N. Takahashi, R. Kawakami, K. Tanimoto, Y. Nakagawa, et al.
Guanylyl Cyclase-A Inhibits Angiotensin II Type 1A Receptor-Mediated Cardiac Remodeling, an Endogenous Protective Mechanism in the Heart
Circulation, September 24, 2002; 106(13): 1722 - 1728.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Tokudome, T. Horio, F. Yoshihara, S.-i. Suga, Y. Kawano, M. Kohno, and K. Kangawa
Adrenomedullin Inhibits Doxorubicin-Induced Cultured Rat Cardiac Myocyte Apoptosis via a cAMP-Dependent Mechanism
Endocrinology, September 1, 2002; 143(9): 3515 - 3521.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. J. Ellmers, J. W. Knowles, H.-S. Kim, O. Smithies, N. Maeda, and V. A. Cameron
Ventricular expression of natriuretic peptides in Npr1-/- mice with cardiac hypertrophy and fibrosis
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H707 - H714.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Adler and H. Huang
Impaired Regulation of Renal Oxygen Consumption in Spontaneously Hypertensive Rats
J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1788 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. H. Kim, J. H. Han, C. Cao, S. Z. Kim, and K. W. Cho
Postnatal changes in inhibitory effect of C-type natriuretic peptide on secretion of ANP
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1672 - R1679.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
L King and M R Wilkins
Natriuretic peptide receptors and the heart
Heart, April 1, 2002; 87(4): 314 - 315.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. A Babiker, L. J De Windt, M. van Eickels, C. Grohe, R. Meyer, and P. A Doevendans
Estrogenic hormone action in the heart: regulatory network and function
Cardiovasc Res, February 15, 2002; 53(3): 709 - 719.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. F. Deschepper, I. Boutin-Ganache, A. Zahabi, and Z. Jiang
In Search of Cardiovascular Candidate Genes: Interactions Between Phenotypes and Genotypes
Hypertension, February 1, 2002; 39(2): 332 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Klinger, R. R. Warburton, L. Pietras, P. Oliver, J. Fox, O. Smithies, and N. S. Hill
Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H58 - H65.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
T. Omura, M. Yoshiyama, K. Yoshida, Y. Nakamura, S. Kim, H. Iwao, K. Takeuchi, and J. Yoshikawa
Dominant Negative Mutant of c-Jun Inhibits Cardiomyocyte Hypertrophy Induced by Endothelin 1 and Phenylephrine
Hypertension, January 1, 2002; 39(1): 81 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. H. Kim, J. H. Han, S. H. Lim, S. J. Lee, S. Z. Kim, and K. W. Cho
Attenuation of inhibitory effect of CNP on the secretion of ANP from hypertrophied atria
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1456 - R1463.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Foldes, M. Suo, I. Szokodi, Z. Lako-Futo, R. deChatel, O. Vuolteenaho, P. Huttunen, H. Ruskoaho, and M. Toth
Factors Derived from Adrenals Are Required for Activation of Cardiac Gene Expression in Angiotensin II-Induced Hypertension
Endocrinology, October 1, 2001; 142(10): 4256 - 4263.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Schwartzbauer and J. Robbins
Matters of Sex: Sex Matters
Circulation, September 18, 2001; 104(12): 1333 - 1335.
[Full Text] [PDF]

Home page
 CirculationHome page
M. van Eickels, C. Grohe, J. P.M. Cleutjens, B. J. Janssen, H. J.J. Wellens, and P. A. Doevendans
17{beta}-Estradiol Attenuates the Development of Pressure-Overload Hypertrophy
Circulation, September 18, 2001; 104(12): 1419 - 1423.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Hayashi, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, T. Tsutsui, H. Horie, M. Ohnishi, and M. Kinoshita
Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1820 - 1826.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. Kishimoto, K. Rossi, and D. L. Garbers
A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy
PNAS, February 8, 2001; (2001) 51625598.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
C. F. Deschepper, S. Masciotra, A. Zahabi, I. Boutin-Ganache, S. Picard, and T. L. Reudelhuber
Functional Alterations of the Nppa Promoter Are Linked to Cardiac Ventricular Hypertrophy in WKY/WKHA Rat Crosses
Circ. Res., February 2, 2001; 88(2): 223 - 228.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Nishikimi, A. Miyata, T. Horio, F. Yoshihara, N. Nagaya, S. Takishita, C. Yutani, H. Matsuo, H. Matsuoka, and K. Kangawa
Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3031 - H3039.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. Kishimoto, K. Rossi, and D. L. Garbers
A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy
PNAS, February 27, 2001; 98(5): 2703 - 2706.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Jankowski, G. Rachelska, W. Donghao, S. M. McCann, and J. Gutkowska
Estrogen receptors activate atrial natriuretic peptide in the rat heart
PNAS, September 25, 2001; 98(20): 11765 - 11770.
[Abstract] [Full Text] [PDF]


Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.